Trial Profile
Efficacy and safety of tulobuterol patch combined with tiotropium bromide for relieving dyspnea symptom of Chronic Obstructive Pulmonary Disease.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary) ; Tulobuterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 09 Nov 2011 New trial record